| PERIOD ENDING | 2-Aug-08 | 3-May-08 | 2-Feb-08 | 3-Nov-07 | | Total Revenue | 2,287,000 | 1,879,000 | 2,514,186 | 1,970,444 | | Cost of Revenue | 1,488,000 | 1,179,000 | 1,568,822 | 1,228,506 | | | Gross Profit | 799,000 | 700,000 | 945,364 | 741,938 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 604,000 | 545,000 | 637,220 | 552,632 | | Non Recurring |
-
|
-
| 33,925 | (33,925) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 195,000 | 155,000 | 274,219 | 223,231 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 74,000 | 72,000 | 110,054 | 68,779 | | Earnings Before Interest And Taxes | 269,000 | 227,000 | 458,273 | 292,010 | | Interest Expense | 34,000 | 31,000 | 29,569 | 20,408 | | Income Before Tax | 235,000 | 196,000 | 428,704 | 271,602 | | Income Tax Expense | 92,000 | 77,000 | 142,655 | 105,878 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 143,000 | 119,000 | 212,049 | 165,724 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 143,000 | 119,000 | 212,049 | 165,724 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $143,000 | $119,000 | $212,049 | $165,724 |
|
1.49% Nasdaq 0.00%
Income Statement
